| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Nuformix appoints Anne Brindley as CEO
StockMarketWire.com
|
Drug re-purposing specialist Nuformix said it had appointed Anne Brindley as its chief executive.
Brindley was previously CEO of Australia's Advent Pharmaceuticals, a specialty R&D company focused on generic inhaled products for global markets.
She also had been managing director of Respivert, a subsidiary of Janssen Pharmaceuticals. 'I now look forward to working with Anne and the rest of the board as I resume the role of non-executive chairman,' chairman Chris Blackwell said.
Story provided by StockMarketWire.com
|
|
|
|
|
|
